Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)

Completed · Phase 1 · Has a placebo group

Conditions studied: Breast Cancer

In brief

The purpose of this study is to determine whether HKI-272 affects the rhythms of the heart (cardiac repolarization).

Key facts

Study ID

NCT00708903

Run by

Puma Biotechnology, Inc.

People needed

60

Starts

2008-05-01

Expected to finish

2008-07-01

Last updated by the study team

2012-05-14

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Men or women of nonchildbearing potential,
• 18-50 years old.
• Healthy as determined by the investigator, including physical examination, laboratory test results, and medical history.

Where it is running

• Study site — Tacoma, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.